GALACTOSIALIDOSIS

 

GALACTOSIALIDOSIS

 

DEFINITION:

A neurodegenerative disorder characterized by myoclonic seizures, tonic-clonic seizures, progressive neurologic dysfunction (dementia and ataxia), and macular cherry-red spots.

EPIDEMIOLOGY:

  • incidence: rare
  • age of onset:
    • 2nd to 3rd decade
  • risk factors:
    • familial - autosomal recessive
      • chrom.#: 20q13.1
      • gene: ?
    • M = F
    • racial - Japanese

PATHOGENESIS:

1. Background

  • one of the 5 major conditions that account for the majority of cases of "Progressive Myoclonus Epilepsies"
  • considered to be a lysosomal storage disease
  • may be considered a juvenile form of Sialidosis

2. Genetic Defect

  • genetic defect -> deficiency of a 32-kilodalton protein that is essential for the catalytic activity of alpha-N-acetyl-neuraminidase and normally protects beta-galactosidase from degradation -> relative deficiencies of both alpha-N-acetyl-neuraminidase and beta-galactosidase -> accumulation of sialyloligosaccharides and sialylglycopeptides in lymphocytes, fibroblasts, bone marrow cells, Kupffer cells (liver), Schwann cells, etc.

CLINICAL FEATURES:

1. Neurological Manifestations

1. Initial

1. Myoclonic Seizures

  • generalized affecting the extremities
  • triggered by voluntary movement, touch, sound, smoking, menstrual cycle
  • progressive -> nonambulatory

2. Macular Cherry-Red Spot

  • progressive loss of visual acuity
  • gradual loss of vision

2. Later

  • tonic-clonic seizures
  • ataxia
  • mental deterioration -> dementia
  • hearing loss

2. Others

  • coarse facies
  • angiokeratoma corporis diffusum

INVESTIGATIONS:

1. Imaging Studies

1. CT/MRI

  • generalized cerebral atrophy

2. Skeletal X-Rays

  • dysostosis multiplex

2. Pathology

1. Sialyloligosaccharides/Sialylglycopeptides

  • detected by light microscopy
  • periodic acid-Shiff-positive inclusions (vacuolations) within cells throughout the body
  • represents the lysosomal storage material

3. Urine

  • increased secretion of sialyloligosacchraides and sialylglycopeptides detected by thin-layer chromatography

4. Diagnostic

  • deficiency of alpha-N-acetylneuraminidase and beta-galactosidase activites in leukocytes or cultured skin fibroblasts
  • prenatal:
    • deficiency of alpha-N-acetylneuraminidase and beta-galactosidase activities in cultured chorionic villi or amniocytes

MANAGEMENT:

1. Supportive

  • no treatment available for the disorder
  • multidisciplinary approach to ongoing problems
    • Paediatrics, Neurology, Ortho, PT, OT, Ophthalmology
    • myoclonic seizures difficult to control

 

 

 

Pediatric Database - GALACTOSIALIDOSIS

Pediatric Organization - Pedbase [at] Gmail.com